Literature DB >> 16920636

The many roads to inflammatory bowel diseases.

M F Neurath1, S Finotto.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920636     DOI: 10.1016/j.immuni.2006.08.005

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


× No keyword cloud information.
  5 in total

Review 1.  The role of polymorphonuclear leukocyte trafficking in the perpetuation of inflammation during inflammatory bowel disease.

Authors:  Jennifer C Brazil; Nancy A Louis; Charles A Parkos
Journal:  Inflamm Bowel Dis       Date:  2013-06       Impact factor: 5.325

2.  Lack of evidence for association of primary sclerosing cholangitis and primary biliary cirrhosis with risk alleles for Crohn's disease in Polish patients.

Authors:  Pawel Gaj; Andrzej Habior; Michal Mikula; Jerzy Ostrowski
Journal:  BMC Med Genet       Date:  2008-08-21       Impact factor: 2.103

Review 3.  Modulation by melatonin of the pathogenesis of inflammatory autoimmune diseases.

Authors:  Gu-Jiun Lin; Shing-Hwa Huang; Shyi-Jou Chen; Chih-Hung Wang; Deh-Ming Chang; Huey-Kang Sytwu
Journal:  Int J Mol Sci       Date:  2013-05-31       Impact factor: 5.923

4.  Evaluation of Melatonin Secretion and Metabolism Exponents in Patients with Ulcerative and Lymphocytic Colitis.

Authors:  Cezary Chojnacki; Janusz Błasiak; Jakub Fichna; Jan Chojnacki; Tomasz Popławski
Journal:  Molecules       Date:  2018-01-29       Impact factor: 4.411

5.  Therapeutic Potential of a Self-Assembling Peptide Hydrogel to Treat Colonic Injuries Associated with Inflammatory Bowel Disease.

Authors:  Toshihiro Araki; Keiichi Mitsuyama; Hiroshi Yamasaki; Masaru Morita; Kozo Tsuruta; Atsushi Mori; Tetsuhiro Yoshimura; Shuhei Fukunaga; Kotaro Kuwaki; Shinichiro Yoshioka; Hidetoshi Takedatsu; Tatsuyuki Kakuma; Jun Akiba; Takuji Torimura
Journal:  J Crohns Colitis       Date:  2021-09-25       Impact factor: 9.071

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.